Price data is not available
Spruce Biosciences Inc (SPRB) Stock Price, Quote, News & History
SPRBNASDAQ
Spruce Biosciences (SPRB) shares drop 21% in premarket trading following a $60 million public stock offering priced at $50 per share.
You can purchase shares of Spruce Biosciences (NASDAQ:SPRB) through any online brokerage.
Other companies in Spruce Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Spruce Biosciences has a consensus price target of $156.05.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $41 last updated November 9, 2026 at 9:25 AM EST.
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates...
